Cytiva, a Danaher company, and WhiteLab Genomics, a techbio company specialising in artificial intelligence for genomic medicine research and development, announced a collaboration to accelerate the development of next-generation genomic medicines.
Aenova, a global contract development and manufacturing organisation (CDMO), is expanding its microbiology quality control (QC) laboratory at its Latina site.
Scenic Biotech, a pioneer in the field of modifier therapies for severe diseases, has announced the appointment of Roland W. Bürli, PhD, as chief scientific officer (CSO).
Haughton Design, a UK-based product design consultancy specialising in medical devices, drug delivery systems and healthcare technology, has appointed Dr Ash Ghadar as chief executive officer (CEO) to lead the company’s next phase of growth.
eXmoor Pharma, the integrated cell and gene therapy CDMO, has announced a new strategic partnership with Anthony Nolan: Cell Therapy & Laboratory Services (CT&LS).
One2Treat, a technology company transforming how the patient voice is integrated into clinical development, has announced the successful completion of a planned seed extension to accelerate its software platform development.
Europa Biosite has announced that Bio X Cell has appointed Cambridge Bioscience, a member of Europa Biosite, as its exclusive distributor for the United Kingdom and Ireland.
Gifthealth has announced its acquisition of Occam Health Services creating the "first-of-its-kind" digital pharmacy platform and patient access hub solution.
Polpharma Biologics has announced that it has signed licensing agreements with MS Pharma for the commercialisation of its biosimilar candidates vedolizumab (PB016), ocrelizumab (PB018) and guselkumab (PB019) in the MENA region.
